(Q30653549)

English

Guidelines from The Italian Neurological and Neuroradiological Societies for the use of magnetic resonance imaging in daily life clinical practice of multiple sclerosis patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 June 2017

Guidelines from The Italian Neurological and Neuroradiological Societies for the use of magnetic resonance imaging in daily life clinical practice of multiple sclerosis patients (English)

1 reference

Europe PubMed Central

25 June 2017

multiple sclerosis

0 references

Stefano Bastianello

object named as

Stefano Bastianello

3

0 references

object named as

Andrea Falini

14

0 references

Maria Giovanna Marrosu

object named as

Maria Giovanna Marrosu

8

0 references

Nicola De Stefano

object named as

Nicola De Stefano

15

0 references

object named as

Maria Trojano

13

0 references

object named as

Maria A Rocca

2

0 references

Massimo Filippi

object named as

Massimo Filippi

1

0 references

4

object named as

Giancarlo Comi

1 reference

Europe PubMed Central

25 June 2017

7

object named as

Angelo Ghezzi

1 reference

Europe PubMed Central

25 June 2017

Gioacchino Tedeschi

12

object named as

Gioacchino Tedeschi

1 reference

Europe PubMed Central

25 June 2017

Giorgio Minonzio

9

object named as

Giorgio Minonzio

1 reference

Europe PubMed Central

25 June 2017

pantano patrizia

10

object named as

Patrizia Pantano

1 reference

Europe PubMed Central

25 June 2017

11

object named as

Carlo Pozzilli

1 reference

Europe PubMed Central

25 June 2017

author name string

Paolo Gallo

5

1 reference

Europe PubMed Central

25 June 2017

Massimo Gallucci

6

1 reference

Europe PubMed Central

25 June 2017

Neuroimaging and MS Study Groups of the Italian Society of Neurology

16

1 reference

Europe PubMed Central

25 June 2017

Functional Neuroradiology Section of the Italian Association of Neuroradiology

17

1 reference

Europe PubMed Central

25 June 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

5 July 2013

1 reference

Europe PubMed Central

25 June 2017

Neurological Sciences

1 reference

Europe PubMed Central

25 June 2017

34

1 reference

Europe PubMed Central

25 June 2017

12

1 reference

Europe PubMed Central

25 June 2017

2085-2093

1 reference

Europe PubMed Central

25 June 2017

https://scigraph.springernature.com/pub.10.1007/s10072-013-1485-7

0 references

MR imaging of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1485-7

21 January 2018

Magnetic Resonance Techniques in Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1485-7

21 January 2018

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1485-7

21 January 2018

MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation".

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1485-7

21 January 2018

Differential diagnosis of suspected multiple sclerosis: a consensus approach

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1485-7

21 January 2018

Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1485-7

21 January 2018

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1485-7

21 January 2018

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1485-7

21 January 2018

Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1485-7

21 January 2018

The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study.

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1485-7

21 January 2018

Effect of training and different measurement strategies on the reproducibility of brain MRI lesion load measurements in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1485-7

21 January 2018

Improving interobserver variation in reporting gadolinium-enhanced MRI lesions in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1485-7

21 January 2018

Spinal-cord MRI in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1485-7

21 January 2018

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1485-7

21 January 2018

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1485-7

21 January 2018

MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study.

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1485-7

21 January 2018

Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1485-7

21 January 2018

Defining interferon beta response status in multiple sclerosis patients.

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1485-7

21 January 2018

Predictors of long-term clinical response to interferon beta therapy in relapsing multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1485-7

21 January 2018

Scoring treatment response in patients with relapsing multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1485-7

21 January 2018

Refining response to treatment as defined by the Modified Rio Score.

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1485-7

21 January 2018

Relationship between MRI lesion activity and response to IFN-β in relapsing–remitting multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1485-7

21 January 2018

Measures in the first year of therapy predict the response to interferon β in MS

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1485-7

21 January 2018

Strategies for optimizing MRI techniques aimed at monitoring disease activity in multiple sclerosis treatment trials

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1485-7

21 January 2018

Treatment optimization in MS: Canadian MS Working Group updated recommendations.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23828372

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23828372

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment optimization in multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23828372

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/23828372

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10072-013-1485-7

1 reference

Europe PubMed Central

25 June 2017

1 reference

Europe PubMed Central

25 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30653549&oldid=1743963883"